Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics

CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders - Cytotherapy

Frontiers CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte -based adoptive T cell therapy: Molecular Therapy - Oncolytics

CRISPR/Cas9 encouraged CAR-T cell immunotherapy reporting efficient and safe clinical results towards cancer - ScienceDirect

Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer

Frontiers The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte -based adoptive T cell therapy: Molecular Therapy - Oncolytics

Frontiers CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer

Cancer Immunotherapy Therapeutic Strategies in Veterinary Oncology

Cellular Therapy in NSCLC: Between Myth and Reality